What it's for (Indications)
- Dimemorfan phosphate is clinically indicated for the symptomatic relief of cough of various etiologies.
- This includes acute and chronic cough associated with common respiratory conditions such as the common cold, acute bronchitis, chronic bronchitis, pharyngitis, laryngitis, tracheitis, and influenza.
- As a non-opioid antitussive, its primary role is to suppress persistent and bothersome coughs, particularly dry, non-productive coughs that can interfere with daily activities or sleep.
- It acts to alleviate the discomfort and irritation caused by coughing, thereby improving the patient's quality of life during the course of their respiratory illness.
- It is important to note that dimemorfan phosphate provides symptomatic relief and does not address the underlying cause of the cough, which may require separate diagnostic evaluation and specific treatment.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of dimemorfan phosphate should be individualized based on the patient's age, medical condition, and response to treatment, and should always be determined by a healthcare professional. For adult patients, the typical oral dose is 10 mg to 30 mg, administered two to three times daily. The total daily dose should generally not exceed 90 mg. Dimemorfan phosphate is available in various formulations, including tablets and syrups, to facilitate accurate dosing. For pediatric patients, specific dosing guidelines based on age and weight should be strictly followed, and administration should only occur under the guidance of a physician. It is crucial to adhere to the prescribed dose and frequency and not to exceed the recommended maximum daily dose to minimize the risk of adverse effects. Patients with impaired renal or hepatic function may require dose adjustments. |
Safety & Warnings
Common Side Effects
- Dimemorfan phosphate is generally well-tolerated at therapeutic doses, with most reported side effects being mild and transient.
- Common side effects may include gastrointestinal disturbances such as nausea, dry mouth, or constipation.
- Central nervous system effects, though usually mild, can occur and may include dizziness, lightheadedness, or drowsiness, which could impair the ability to perform tasks requiring mental alertness.
- Headaches have also been reported infrequently.
- Less common side effects might include skin rashes or other hypersensitivity reactions.
- Patients are advised to consult their healthcare provider if any side effects become bothersome, persistent, or worsen, or if they experience any signs of an allergic reaction such as swelling of the face, lips, tongue, or throat, or difficulty breathing.
- The incidence of serious adverse events is rare.
Serious Warnings
- Black Box Warning: While dimemorfan phosphate does not carry an official FDA Black Box Warning, healthcare professionals must exercise extreme caution regarding several serious safety considerations. The concomitant use of dimemorfan phosphate with Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of discontinuing MAOI therapy, is strictly contraindicated due to the substantial risk of precipitating Serotonin Syndrome. This potentially life-threatening condition manifests with symptoms such as mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular abnormalities (e.g., hyperreflexia, incoordination), and gastrointestinal symptoms. Furthermore, although dimemorfan phosphate is a non-narcotic antitussive, there remains a potential for abuse and misuse, particularly at supratherapeutic doses, which can lead to central nervous system depression, dissociative effects, and other severe adverse reactions. Caution is also warranted in patients with underlying respiratory compromise or severe hepatic impairment, as altered drug metabolism and increased susceptibility to adverse effects may occur, necessitating close monitoring and potential dose adjustments. Patients should be advised against exceeding recommended dosages to mitigate these significant safety risks.
- Patients with a known hypersensitivity to dimemorfan phosphate or any of its excipients should not use this medication.
- Caution is advised in patients with pre-existing hepatic or renal impairment, as dose adjustments may be necessary, and monitoring of liver and kidney function may be warranted.
- Due to the potential for drowsiness or dizziness, patients should be advised to exercise caution when driving or operating heavy machinery until they know how dimemorfan phosphate affects them.
- Concomitant use with other central nervous system depressants, including alcohol, sedatives, or hypnotics, should be approached with caution due to the potential for additive depressant effects.
- Dimemorfan phosphate is intended for the suppression of non-productive cough; it is generally not recommended for coughs where expectoration is necessary for clearing respiratory secretions.
- Use in pregnant or lactating women should only be considered if the potential benefits outweigh the potential risks, and under strict medical supervision.
How it Works (Mechanism of Action)
Dimemorfan phosphate exerts its antitussive effect through a central mechanism of action, primarily by suppressing the cough reflex within the medulla oblongata of the brain. It acts selectively on the cough center, elevating the cough threshold without exerting significant effects on the respiratory center. Unlike opioid antitussives, dimemorfan phosphate does not bind to opioid receptors in the central nervous system, meaning it lacks analgesic properties, has negligible potential for abuse, and does not cause respiratory depression at clinically relevant doses. Its pharmacological profile suggests a modulatory effect on neurotransmission pathways involved in the cough reflex, though the precise molecular targets are still a subject of ongoing research. The result is a reduction in the frequency and intensity of coughing, providing symptomatic relief for patients experiencing various types of cough.
Commercial Brands (Alternatives)
No other brands found for this formula.